JP4916306B2 - 安全性が改善された高電力埋め込み可能電池及び製造方法 - Google Patents
安全性が改善された高電力埋め込み可能電池及び製造方法 Download PDFInfo
- Publication number
- JP4916306B2 JP4916306B2 JP2006509602A JP2006509602A JP4916306B2 JP 4916306 B2 JP4916306 B2 JP 4916306B2 JP 2006509602 A JP2006509602 A JP 2006509602A JP 2006509602 A JP2006509602 A JP 2006509602A JP 4916306 B2 JP4916306 B2 JP 4916306B2
- Authority
- JP
- Japan
- Prior art keywords
- cell
- rate
- electrochemical cell
- providing
- high rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 239000003792 electrolyte Substances 0.000 claims description 17
- 238000002560 therapeutic procedure Methods 0.000 claims description 9
- 230000003213 activating effect Effects 0.000 claims description 5
- 239000008151 electrolyte solution Substances 0.000 claims description 4
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 3
- 230000009977 dual effect Effects 0.000 description 15
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 14
- 238000010586 diagram Methods 0.000 description 13
- 238000013461 design Methods 0.000 description 11
- 230000000638 stimulation Effects 0.000 description 10
- RAVDHKVWJUPFPT-UHFFFAOYSA-N silver;oxido(dioxo)vanadium Chemical compound [Ag+].[O-][V](=O)=O RAVDHKVWJUPFPT-UHFFFAOYSA-N 0.000 description 9
- 229910052744 lithium Inorganic materials 0.000 description 8
- 239000003990 capacitor Substances 0.000 description 6
- 210000003748 coronary sinus Anatomy 0.000 description 5
- 229910001947 lithium oxide Inorganic materials 0.000 description 5
- 208000003663 ventricular fibrillation Diseases 0.000 description 5
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 239000010406 cathode material Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 2
- 206010049447 Tachyarrhythmia Diseases 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 238000013194 cardioversion Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910001416 lithium ion Inorganic materials 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- XHCLAFWTIXFWPH-UHFFFAOYSA-N [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] XHCLAFWTIXFWPH-UHFFFAOYSA-N 0.000 description 1
- FTIBOXCCLJXFFK-UHFFFAOYSA-N [V].[Ag].[Cu]=O Chemical compound [V].[Ag].[Cu]=O FTIBOXCCLJXFFK-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000010405 anode material Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229910000464 lead oxide Inorganic materials 0.000 description 1
- 210000005248 left atrial appendage Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- INHCSSUBVCNVSK-UHFFFAOYSA-L lithium sulfate Inorganic materials [Li+].[Li+].[O-]S([O-])(=O)=O INHCSSUBVCNVSK-UHFFFAOYSA-L 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N oxolead Chemical compound [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229910001935 vanadium oxide Inorganic materials 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/36—Selection of substances as active materials, active masses, active liquids
- H01M4/38—Selection of substances as active materials, active masses, active liquids of elements or alloys
- H01M4/381—Alkaline or alkaline earth metals elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3975—Power supply
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M6/00—Primary cells; Manufacture thereof
- H01M6/14—Cells with non-aqueous electrolyte
- H01M6/16—Cells with non-aqueous electrolyte with organic electrolyte
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
- A61N1/3962—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion in combination with another heart therapy
- A61N1/39622—Pacing therapy
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/36—Selection of substances as active materials, active masses, active liquids
- H01M4/48—Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides
- H01M4/50—Selection of substances as active materials, active masses, active liquids of inorganic oxides or hydroxides of manganese
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M6/00—Primary cells; Manufacture thereof
- H01M6/42—Grouping of primary cells into batteries
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/10—Energy storage using batteries
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P70/00—Climate change mitigation technologies in the production process for final industrial or consumer products
- Y02P70/50—Manufacturing or production processes characterised by the final manufactured product
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Manufacturing & Machinery (AREA)
- Electrotherapy Devices (AREA)
- Primary Cells (AREA)
- Secondary Cells (AREA)
- Battery Electrode And Active Subsutance (AREA)
Description
第2の高レート電気化学セルを設けるステップであって、第2カソード集電体を有する第2カソードを設けるステップと、第2外部リード線を第2カソード集電体に接続するステップと、第2カソードと動作可能に連結する電解質溶液によって、第2電気化学セルを活性化するステップとを含む、第2の高レート電気化学セルを設けるステップと、(c)アノードを、第1の高レートセル及び第2の高レートセル内の電解質と電気的に連結させるステップであって、第1のセルは第2のセルに並列に接続される、連結させるステップと、d)第1外部リード線と第2外部リード線の間で少なくとも1つの抵抗負荷を電気的に接続するステップと、(e)アノードを電池ケーシングに接続するステップであって、それによって、ケーシング上に負電荷を生成する、接続するステップと、のうちの1つ又は複数を含んでもよい。
Claims (4)
- 埋め込み可能医療デバイスであって、
密閉格納容器と、
該格納容器内に配置される低電力制御回路と、
電気パルス治療を送出するための、前記格納容器内に配置される高電力出力回路と、
前記低電力制御回路及び前記高電力出力回路を駆動するための、前記格納容器内に配置される電源及び回路要素であって、第1の高レートセルと、第2の高レートセルとをさらに備え、前記第1の高レートセル及び前記第2の高レートセルは、前記低電力制御回路及び前記高電力出力回路に並列に電気的に接続される、前記電源及び回路要素と、
前記第1の高レートセルと前記第2の高レートセルの間で電気的に接続される少なくとも1つの抵抗負荷であって、前記第1の高レートセルが内部短絡する場合に、前記内部短絡した第1の高レートセルが前記第2の高レートセルに流れ込むレートを制限するための抵抗値を有する、少なくとも1つの抵抗負荷と、
を備え、
前記少なくとも1つの抵抗負荷値は10オーム〜100オームであり、
高レートセルが、0.1ジュールから40ジュールのエネルギーを提供する能力を持つセルである埋め込み可能医療デバイス。 - 電気化学電池であって、
a)第1の高レート電気化学セルであって、
i)第1アノードと、
ii)該第1アノードを第1外部リード線に接続する第1端子と、
iii)前記第1アノードと動作可能に連結する第1電解質と、
を備える、第1の高レート電気化学セルと、
b)第2の高レート電気化学セルであって、
i)第2アノードと、
ii)該第2アノードを第2外部リード線に接続する第2端子と、
iii)前記第2アノードと動作可能に連結する第2電解質と、
を備える、第2の高レート電気化学セルと、
c)前記第1電解質及び前記第2電解質と電気的に連結するカソードであって、前記第1の高レート電気化学セルは前記第2の高レート電気化学セルに並列に接続される、カソードと、
d)前記第1外部リード線と前記第2外部リード線の間で電気的に接続される少なくとも1つの抵抗負荷とを備え、
前記少なくとも1つの抵抗負荷値は10オーム〜100オームであり、
高レートセルが、0.1ジュールから40ジュールのエネルギーを提供する能力を持つセルである電気化学電池。 - 電気化学電池を製造する方法であって、
a)第1の高レート電気化学セルを設けるステップであって、
i)第1カソードを設けるステップと、
ii)第1外部リード線を前記第1カソードに接続するステップと、
iii)前記第1カソードと動作可能に連結する電解質溶液によって、前記第1の高レート電気化学セルを活性化するステップと、
を含む、第1の高レート電気化学セルを設けるステップと、
b)第2の高レート電気化学セルを設けるステップであって、
i)第2カソードを設けるステップと、
ii)第2外部リード線を前記第2カソードに接続するステップと、
iii)前記第2カソードと動作可能に連結する電解質溶液によって、前記第2電気化学セルを活性化するステップと、
を含む、第2の高レート電気化学セルを設けるステップと、
c)アノードを、前記第1の高レート電気化学セル及び前記第2の高レート電気化学セル内の前記電解質と電気的に連結させるステップであって、前記第1の高レート電気化学セルは、前記第2の高レート電気化学セルに並列に接続される、連結させるステップと、
d)前記第1外部リード線と前記第2外部リード線の間で少なくとも1つの抵抗負荷を電気的に接続するステップとを含み、
前記少なくとも1つの抵抗負荷値は10オーム〜100オームであり、
高レートセルが、0.1ジュールから40ジュールのエネルギーを提供する能力を持つセルである、電気化学電池を製造する方法。 - 埋め込み可能医療デバイスを製造する方法であって、
a)密閉格納容器を設けるステップと、
b)該格納容器内に低電力制御回路を設けるステップと、
c)電気パルス治療を送出するために、前記格納容器内に高電力出力回路を設けるステップと、
d)前記低電力制御回路及び前記高電力出力回路を駆動するために、前記格納容器内に電源及び回路要素を設けるステップであって、
i)第1の高レートセルを設けるステップと、
ii)第2の高レートセルを設けるステップと、
iii)前記第1の高レートセル及び前記第2の高レートセルを、前記低電力制御回路及び前記高電力出力回路に並列に接続するステップと、
iv)前記第1の高レートセルと前記第2の高レートセルの間に少なくとも1つの抵抗負荷を電気的に接続するステップと、
を含む、電源及び回路要素を設けるステップと、
を含み、
前記少なくとも1つの抵抗負荷値は10オーム〜100オームであり、
高レートセルが、0.1ジュールから40ジュールのエネルギーを提供する能力を持つセルである、埋め込み可能医療デバイスを製造する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/403,114 | 2003-03-31 | ||
US10/403,114 US7209784B2 (en) | 2003-03-31 | 2003-03-31 | High power implantable battery with improved safety and method of manufacture |
PCT/US2004/010103 WO2004091021A1 (en) | 2003-03-31 | 2004-03-31 | High power implantable battery with improved safety and method of manufacture |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006523134A JP2006523134A (ja) | 2006-10-12 |
JP4916306B2 true JP4916306B2 (ja) | 2012-04-11 |
Family
ID=32989851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006509602A Expired - Fee Related JP4916306B2 (ja) | 2003-03-31 | 2004-03-31 | 安全性が改善された高電力埋め込み可能電池及び製造方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US7209784B2 (ja) |
EP (4) | EP1742284B1 (ja) |
JP (1) | JP4916306B2 (ja) |
CA (1) | CA2520780A1 (ja) |
DE (3) | DE602004018841D1 (ja) |
WO (1) | WO2004091021A1 (ja) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7725182B2 (en) * | 2005-05-31 | 2010-05-25 | Marvell World Trade Ltd. | Power distribution system for a medical device |
US8685568B2 (en) * | 2006-02-01 | 2014-04-01 | Greatbatch Ltd. | Lithium/fluorinated carbon cell for high-rate pulsatlie applications |
US8048557B2 (en) * | 2007-02-01 | 2011-11-01 | Eaglepicher Energy Products Corporation | Electrochemical device |
WO2009081262A1 (en) | 2007-12-18 | 2009-07-02 | Insuline Medical Ltd. | Drug delivery device with sensor for closed-loop operation |
US9220837B2 (en) | 2007-03-19 | 2015-12-29 | Insuline Medical Ltd. | Method and device for drug delivery |
KR20090128499A (ko) | 2007-03-19 | 2009-12-15 | 인슐린 메디컬 엘티디 | 약물 전달 장치 |
US8622991B2 (en) | 2007-03-19 | 2014-01-07 | Insuline Medical Ltd. | Method and device for drug delivery |
US7962212B2 (en) * | 2007-08-02 | 2011-06-14 | Cameron Health, Inc. | Multiple battery configurations in an implantable medical device |
CN102245137A (zh) | 2008-11-07 | 2011-11-16 | 茵苏莱恩医药有限公司 | 用于药物递送的装置和方法 |
US9694192B2 (en) | 2013-10-04 | 2017-07-04 | Boston Scientific Neuromodulation Corporation | Implantable medical device with a primary and rechargeable battery |
US9345883B2 (en) | 2014-02-14 | 2016-05-24 | Boston Scientific Neuromodulation Corporation | Rechargeable-battery implantable medical device having a primary battery active during a rechargeable-battery undervoltage condition |
US9861827B2 (en) | 2014-09-08 | 2018-01-09 | Medtronic, Inc. | Implantable medical devices having multi-cell power sources |
US9579517B2 (en) | 2014-09-08 | 2017-02-28 | Medtronic, Inc. | Transformer-based charging circuits for implantable medical devices |
US9724528B2 (en) | 2014-09-08 | 2017-08-08 | Medtronic, Inc. | Multiple transformer charging circuits for implantable medical devices |
US9604071B2 (en) | 2014-09-08 | 2017-03-28 | Medtronic, Inc. | Implantable medical devices having multi-cell power sources |
US9539435B2 (en) | 2014-09-08 | 2017-01-10 | Medtronic, Inc. | Transthoracic protection circuit for implantable medical devices |
US9861828B2 (en) | 2014-09-08 | 2018-01-09 | Medtronic, Inc. | Monitoring multi-cell power source of an implantable medical device |
US9643025B2 (en) | 2014-09-08 | 2017-05-09 | Medtronic, Inc. | Multi-primary transformer charging circuits for implantable medical devices |
US9960432B2 (en) | 2015-03-26 | 2018-05-01 | Medtronic, Inc. | Adjustable battery stack and method of use in device enclosure |
CA3073172A1 (en) | 2015-04-03 | 2016-10-06 | Conmed Corporation | Autoclave tolerant battery powered motorized surgical hand piece tool and motor control method |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3770504A (en) | 1970-12-21 | 1973-11-06 | Esb Inc | High discharge rate multicell battery |
US4119720A (en) | 1977-07-06 | 1978-10-10 | Sandoz, Inc. | Unsaturated esters of 4-hydroxy-2-quinolinone-3-carboxylic acids and salts thereof |
US4204036A (en) | 1979-03-29 | 1980-05-20 | Polaroid Corporation | Multiple duty battery |
US4375817A (en) | 1979-07-19 | 1983-03-08 | Medtronic, Inc. | Implantable cardioverter |
US4964877A (en) | 1986-01-14 | 1990-10-23 | Wilson Greatbatch Ltd. | Non-aqueous lithium battery |
US5306581A (en) | 1989-06-15 | 1994-04-26 | Medtronic, Inc. | Battery with weldable feedthrough |
US5364654A (en) | 1990-06-14 | 1994-11-15 | Idemitsu Kosan Co., Ltd. | Process for production of a thin film electrode and an electroluminescence device |
US5221453A (en) | 1990-09-27 | 1993-06-22 | Medtronic, Inc. | Silver vanadium oxide cathode material and method of preparation |
US5235979B1 (en) | 1991-03-15 | 1994-11-01 | Angeion Corp | Dual battery system for implantable defibrillator |
US5383907A (en) | 1992-12-18 | 1995-01-24 | Angeion Corporation | System and method for delivering multiple closely spaced defibrillation pulses |
US5147737A (en) | 1991-05-07 | 1992-09-15 | Wilson Greatbatch Ltd. | Electrochemical cell with improved efficiency serpentine electrode |
US5250373A (en) | 1991-09-10 | 1993-10-05 | Wilson Greatbatch Ltd. | Internal electrode and assembly method for electrochemical cells |
US5674248A (en) | 1995-01-23 | 1997-10-07 | Angeion Corporation | Staged energy concentration for an implantable biomedical device |
US5836973A (en) | 1992-12-18 | 1998-11-17 | Kroll; Mark W. | Staged energy concentration for an implantable biomedical device |
US5357795A (en) | 1993-03-17 | 1994-10-25 | Djorup Robert Sonny | Anemometer transducer wind set |
US5434017A (en) | 1993-11-19 | 1995-07-18 | Medtronic, Inc. | Isolated connection for an electrochemical cell |
US5439760A (en) | 1993-11-19 | 1995-08-08 | Medtronic, Inc. | High reliability electrochemical cell and electrode assembly therefor |
US5435017A (en) * | 1993-12-15 | 1995-07-25 | Pan; Chien-Pang | Apparatus for automatically but delayedly lifting a toilet seat |
US5549717A (en) | 1994-03-03 | 1996-08-27 | Wilson Greatbatch Ltd. | Method of making prismatic cell |
US5614331A (en) | 1995-12-22 | 1997-03-25 | Wilson Greatbatch Ltd. | Medium and high discharge rate combination battery and method |
US6088625A (en) * | 1996-08-23 | 2000-07-11 | Kellstrom, Jr.; Gary E. | System for transferring assembly data and method therefor |
US6038473A (en) | 1997-04-08 | 2000-03-14 | Survivalink Corporation | Defibrillator battery with dual cell stack configuration |
EP0872261B1 (de) | 1997-04-16 | 2004-05-06 | LITRONIK Batterietechnologie GmbH & Co. | Implantierbares medizinisches Mehrfunktionsgerät |
US5814075A (en) | 1997-06-17 | 1998-09-29 | Pacesetter, Inc. | Method and apparatus for optimizing source allocation within an implantable cardioverter-defibrillator |
CA2297953A1 (en) * | 1997-07-25 | 1999-02-04 | Cardiac Pacemakers, Inc. | Battery system for implantable medical device |
US6040082A (en) | 1997-07-30 | 2000-03-21 | Medtronic, Inc. | Volumetrically efficient battery for implantable medical devices |
US6008625A (en) | 1998-01-16 | 1999-12-28 | Wilson Greatbatch Ltd. | Use of double cells to power an implantable medical device |
DE19837912C1 (de) | 1998-08-20 | 1999-10-28 | Implex Hear Tech Ag | Energieversorgungsmodul für eine implantierbare Vorrichtung |
US6163723A (en) * | 1998-10-22 | 2000-12-19 | Medtronic, Inc. | Circuit and method for implantable dual sensor medical electrical lead |
US6627337B2 (en) | 2000-02-16 | 2003-09-30 | Wilson Greatbatch Ltd. | Conversion of low rate energy into high rate energy by parallel discharging |
US7191008B2 (en) | 2001-05-30 | 2007-03-13 | Medtronic, Inc. | Implantable medical device with a dual power source |
US6650942B2 (en) | 2001-05-30 | 2003-11-18 | Medtronic, Inc. | Implantable medical device with dual cell power source |
US20040064163A1 (en) | 2002-09-30 | 2004-04-01 | Aamodt Paul B. | Contoured battery for implantable medical devices and method of manufacture |
-
2003
- 2003-03-31 US US10/403,114 patent/US7209784B2/en active Active
-
2004
- 2004-03-31 EP EP06020748A patent/EP1742284B1/en not_active Expired - Fee Related
- 2004-03-31 EP EP08016305A patent/EP1995806B1/en not_active Expired - Fee Related
- 2004-03-31 DE DE602004018841T patent/DE602004018841D1/de not_active Expired - Lifetime
- 2004-03-31 CA CA002520780A patent/CA2520780A1/en not_active Abandoned
- 2004-03-31 EP EP04758748A patent/EP1611630B1/en not_active Expired - Lifetime
- 2004-03-31 EP EP06020749A patent/EP1746677B1/en not_active Expired - Fee Related
- 2004-03-31 JP JP2006509602A patent/JP4916306B2/ja not_active Expired - Fee Related
- 2004-03-31 DE DE602004005975T patent/DE602004005975T2/de not_active Expired - Lifetime
- 2004-03-31 DE DE602004018840T patent/DE602004018840D1/de not_active Expired - Lifetime
- 2004-03-31 WO PCT/US2004/010103 patent/WO2004091021A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP1746677B1 (en) | 2008-12-31 |
EP1995806A1 (en) | 2008-11-26 |
US7209784B2 (en) | 2007-04-24 |
WO2004091021A1 (en) | 2004-10-21 |
EP1746677A1 (en) | 2007-01-24 |
DE602004018841D1 (de) | 2009-02-12 |
EP1611630A1 (en) | 2006-01-04 |
EP1742284B1 (en) | 2008-12-31 |
CA2520780A1 (en) | 2004-10-21 |
EP1995806B1 (en) | 2011-10-05 |
DE602004018840D1 (de) | 2009-02-12 |
DE602004005975D1 (de) | 2007-05-31 |
DE602004005975T2 (de) | 2008-01-17 |
EP1742284A1 (en) | 2007-01-10 |
EP1611630B1 (en) | 2007-04-18 |
US20040193227A1 (en) | 2004-09-30 |
JP2006523134A (ja) | 2006-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6650942B2 (en) | Implantable medical device with dual cell power source | |
US7191008B2 (en) | Implantable medical device with a dual power source | |
JP4916306B2 (ja) | 安全性が改善された高電力埋め込み可能電池及び製造方法 | |
US7337001B2 (en) | Implantable medical device and method with a dual power source incorporating electrolyte additive 2,2,2-trifluoroacetamide | |
US8027728B2 (en) | High power implantable battery with improved safety and method of manufacture | |
US10661089B2 (en) | Electrochemical cell with adjacent cathodes | |
WO2002089904A2 (en) | Implantable medical device with dual cell power source | |
JP2004535230A5 (ja) | ||
EP2783407B1 (en) | Electrochemical cell with adjacent cathodes | |
US20090171419A1 (en) | Capacitor reformation method and device configured to perform the capacitor reformation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070306 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090226 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090526 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090602 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20091021 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111124 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120124 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150203 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4916306 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |